Bisdemethoxycurcumin enhances X-ray-induced apoptosis possibly through p53/Bcl-2 pathway.

Citation data:

Mutation research, ISSN: 1873-135X, Vol: 815, Page: 1-5

Publication Year:
Usage 59
Abstract Views 59
Social Media 1
Tweets 1
Citations 2
Citation Indexes 2
Enomoto, Atsushi, Yamada, Junko, Morita, Akinori, Miyagawa, Kiyoshi
Elsevier BV
Biochemistry, Genetics and Molecular Biology, Environmental Science
Most Recent Tweet View All Tweets
article description
Bisdemethoxycurcumin (BDMC), which is isolated from the rhizomes of Curcuma longa, has anti-inflammatory and anti-carcinogenic activities. Here we found that BDMC enhanced X-ray-induced apoptosis in human T-cell leukemia MOLT-4 cells. Knockdown of p53 significantly attenuated the radiosensitizing effect of BDMC. However, BDMC did not enhance X-ray-mediated activation of the p53 signaling pathway via p53's transactivation or mitochondrial translocation. On the other hand, BDMC promoted the X-ray-induced dephosphorylation at Ser 70 in Bcl-2's flexible loop regulatory domain and Bcl-2 binding to p53. Overexpressing Bcl-2 completely blocked the BDMC's radiosensitization effect. Our results indicate that BDMC stimulates the dephosphorylation and p53-binding activity of Bcl-2 and suggest that BDMC may induce a neutralization of Bcl-2's anti-apoptotic function, thereby enhancing X-ray-induced apoptosis.

This article has 0 Wikipedia reference.